Patents Assigned to DEVELOPMENT FOUNDATION
  • Patent number: 9306167
    Abstract: A field-emission device is disclosed. The device comprises a solid state structure formed of a crystalline material and an amorphous material, wherein an outer surface of the solid state structure is substantially devoid of the amorphous material, and wherein a p-type conductivity of the crystalline material is higher at or near the outer surface than far from the outer surface.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: April 5, 2016
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Rafael Kalish, Moshe Tordjman
  • Patent number: 9303737
    Abstract: A mechanism and method for motion conversion is disclosed. This mechanism can be easily fabricated using standard bulk micromachining technology. Based on this method with appropriate design, a horizontal, in-plane motion can be converted to a vertical or angular displacement out-of-plane. This design has great advantages in micro devices, which are built from a single layer, i.e. wafer fabrication, where an in-plane force is easy to implement, such as by the use of comb drive mechanisms, but an out-of-plane motion may be hard to achieve. The mechanism comprises a pair of beams of different heights, rigidly connected together at a number of points along their length, such that application of an in-plane force to the double beam structure results in out-of-plane motion of the double beam structure at points distant from the point of application of the force.
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: April 5, 2016
    Assignee: Technion Research And Development Foundation Ltd.
    Inventors: David Elata, Arnon Hirshberg
  • Patent number: 9305284
    Abstract: A method for managing communication among a plurality of social network members. The method comprises defining a multi participant task, setting at least one forward rule limiting the distribution an invitation message for participating in the multi participant task, forwarding the invitation message to at least one addressee from a plurality of social network members, allowing the at least one addressee to forward the invitation message to at least one additional addressee from the plurality of social network members under the at least one forward rule, monitoring a plurality of feedbacks to the invitation message to determine whether the multi participant task is achieved, and updating a status of the multi participant task according to the determination.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: April 5, 2016
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Oded Shmueli, Royi Ronen
  • Patent number: 9296102
    Abstract: A robot, a method and a device for controlling a movement of a robot are provided. The method can include controlling multiple steps of the robot. Thus, the method can include multiple iterations of: (i) calculating or receiving a first slope attribute indicative of a slope of a first area of a terrain on which a first leg of the robot steps; (ii) feeding the first slope attribute to a central pattern generator (CPG); and (iii) generating, by the CPG and in response to the slope attribute, at least one control pulse for controlling a torque characteristic of a torque applied by at least one leg of the robot.
    Type: Grant
    Filed: January 6, 2013
    Date of Patent: March 29, 2016
    Assignee: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Jonathan Spitz, Miriam Zacksenhouse
  • Patent number: 9297094
    Abstract: Provided is a method of delivering a medicament or a diagnostic agent to a subject in need thereof by (a) introducing a microtube configured to deliver the medicament or the diagnostic agent into the subject, said microtube comprises an electrospun shell and an electrospun coat over an internal surface of said shell, and (b) administering the medicament or the diagnostic agent through said microtube, thereby delivering the medicament or the diagnostic agent to the subject. Also provided are kits for delivering a medicament or a diagnostic agent.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: March 29, 2016
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.
    Inventor: Eyal Zussman
  • Publication number: 20160084836
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Application
    Filed: August 4, 2015
    Publication date: March 24, 2016
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Jere W. McBRIDE, Christopher K. DOYLE
  • Publication number: 20160074425
    Abstract: A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5? position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders, as well as processes of preparing these aminoglycosides. The disclosed aminoglycosides can be represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification.
    Type: Application
    Filed: September 27, 2015
    Publication date: March 17, 2016
    Applicant: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Timor BAASOV, Dana ATIA-GLIKIN, Jeyakumar KANDASAMY, Valery BELAKHOV
  • Publication number: 20160068862
    Abstract: The present invention provides HIV-derived lentivectors which are safe, highly efficient, and very potent for expressing transgenes for human gene therapy, especially, in human hematopoietic progenitor cells as well as in all other blood cell derivatives. The lentiviral vectors comprise a self-inactivating configuration for biosafety and promoters such as the EF1? promoter as one example. Additional promoters are also described. The vectors can also comprise additional transcription enhancing elements such as the wood chuck hepatitis virus post-transcriptional regulatory element. These vectors therefore provide useful tools for genetic treatments such as inherited and acquired lympho-hematological disorders, gene-therapies for cancers especially the hematological cancers, as well as for the study of hematopoiesis via lentivector-mediated modification of human HSCs.
    Type: Application
    Filed: April 22, 2015
    Publication date: March 10, 2016
    Applicant: Research Development Foundation
    Inventors: Didier TRONO, Patrick SALMON
  • Patent number: 9279412
    Abstract: A control system is presented for controlling operation of a vertical axis wind turbine (VAWT) for generating energy from an incoming fluid flow. The control system comprises at least one flow affecting arrangement associated with at least one blade of the VAWT and a control unit connected to said flow affecting arrangement, the flow affecting arrangement comprising two flow affecting units located in two opposite sides of the blade respectively at a leading edge thereof, each flow affecting unit being operable for creating a blowing jet at the respective side of the blade thereby inducing an increase in a fluid flow momentum, the control unit being configured and operable for selectively activating the flow affecting units in alternating fashion according to a predetermined time pattern to oscillate the blowing jet at the opposite sides of the blade.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: March 8, 2016
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: David Greenblatt, Benyamin Sasson, Magen Schulman
  • Patent number: 9274082
    Abstract: A specified proton concentration in a volume (80) is produced by passing a controlled electrophoresis current through an adjacent electrophoresis volume (28) between a working electrode (26) and a counter electrode (24). An array of such volumes with specified proton concentration is used to provide the pH gradient for isoelectric focusing.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: March 1, 2016
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Uri Sivan, Elad Brod
  • Patent number: 9277330
    Abstract: A system and method for directional sound sensing directs an optical sensing beam to an object of interest having a rough surface that vibrates acoustically. The light is reflected thereby and scattered as a speckle pattern that includes multiple speckles having a random distribution of phase offsets. A detector array having multiple detector elements receives and detects the speckle pattern and produces signals that are linearly proportional to phase modulation of the speckles. A summer receives signals from at least two of the detector elements that are offset at different phases and sums the received signals to generate a non-vanishing signal representative of an acoustic signal.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: March 1, 2016
    Assignee: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Abraham Aharoni, Mordechai Segev, Zvi Katz
  • Patent number: 9260725
    Abstract: The present invention provides HIV-derived lentivectors which are multiply modified to create highly safe, efficient, and potent vectors for expressing transgenes for gene therapy. The lentiviral vectors comprise various combinations of an inactive central polypurine tract, a stuffer sequence, which may encode drug susceptibility genes, and a mutated hairpin in the 5? leader sequence that substantially abolishes replication. These elements are provided in conjunction with other features of lentiviral vectors, such as a self-inactivating configuration for biosafety and promoters such as the EF1? promoter as one example. Additional promoters are also described. The vectors can also comprise additional transcription enhancing elements such as the wood chuck hepatitis virus post-transcriptional regulatory element.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: February 16, 2016
    Assignee: Research Development Foundation
    Inventors: Didier Trono, Romain N. Zufferey
  • Patent number: 9255247
    Abstract: A cell culture comprising human foreskin cells, the human foreskin cells being capable of maintaining stem cells in an undifferentiated state when co-cultured therewith.
    Type: Grant
    Filed: August 19, 2014
    Date of Patent: February 9, 2016
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Michal Amit, Joseph Itskovitz-Eldor
  • Patent number: 9255271
    Abstract: The present disclosure provides pharmaceutical compositions and methods useful for modulating angiogenesis and for inhibiting metastasis, tumors, pulmonary alveolar proteinosis, and fibrosis in a mammalian tissue. Pharmaceutical compositions and methods include inhibitors of LOXL2 expression and activity, such as shRNA targeting LOXL2.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: February 9, 2016
    Assignee: Technion Research & Development Foundation Ltd
    Inventor: Gera Neufeld
  • Publication number: 20160032271
    Abstract: A method of preserving organisms in viable form, the method comprising: suspending organisms in a solution of electrospinnable polymer; drawing droplets of said solution through a spinneret; applying an electrostatic field to said droplets under electrospinning conditions; so as to form fibers having a diameter no greater than about 5 ?m within which distinct organisms are encapsulated in viable form.
    Type: Application
    Filed: August 4, 2015
    Publication date: February 4, 2016
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Jonathan Charles KUHN, Eyal ZUSSMAN
  • Patent number: 9250240
    Abstract: Provided herein are immunoreactive peptides which can selectively bind Ehrlichia-specific anti-p120 or anti-p140 antibodies. Methods and kits utilizing the immunoreactive peptides are also provided. The immunoreactive peptides may be utilized, e.g., for determining whether or not a subject is infected with Ehrlichia chaffeensis or Ehrlichia canis. In certain embodiments, the immunoreactive peptides may be utilized in an ELISA or lateral flow assay.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: February 2, 2016
    Assignee: Research Development Foundation
    Inventors: Jere W. McBride, Tian Luo
  • Publication number: 20160022780
    Abstract: Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility compared to urocortin 2, and pharmaceutical compositions of the polypeptides of the present invention. Also disclosed are polynucleotides encoding the polypeptides, and methods of treating pathophysiological states employing pharmaceutical compositions of the polypeptides and polynucleotides of the present invention. In addition, disclosed are vectors and host cells that include a nucleic acid encoding a polypeptide of the present invention, and kits that include pharmaceutical compositions of the present invention.
    Type: Application
    Filed: October 8, 2015
    Publication date: January 28, 2016
    Applicant: RESEARCH DEVELOPMENT FOUNDATION
    Inventors: Wylie W. VALE, JR., Joan M. VAUGHAN, Cindy DONALDSON, Wolfgang FISCHER, Jean E. F. RIVIER
  • Patent number: 9244070
    Abstract: Methods and compositions for the screening and isolation of ligand-binding polypeptides, such as antibodies. In some aspects, methods of the invention enable the isolation of intact soluble antibodies comprising a constant domain. Screening methods that employ genetic packages such as bacteria and bacteriophages enable high through-put identification of ligand binding molecules.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: January 26, 2016
    Assignee: Research Development Foundation
    Inventors: George Georgiou, Yariv Mazor
  • Patent number: 9234875
    Abstract: Methods and devices for purification of different cell components from the same sample are provided.
    Type: Grant
    Filed: November 5, 2012
    Date of Patent: January 12, 2016
    Assignees: BIO-RAD LABORATORIES, INC., TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.
    Inventors: Aran Paulus, Camille Diges, Roumen Bogoev, Sricharan Bandhakavi, Annett Hanh-Windgassen, Anton Posch, Elad Brod, Uri Sivan
  • Patent number: 9227877
    Abstract: Ceramic nanocomposites and methods for manufacturing the ceramic nanocomposites are disclosed. One method includes introducing to a fired green ceramic body having a ceramic matrix submicron particles having coefficient of thermal expansion lower than the coefficient of thermal expansion of the ceramic matrix and at least one type of location-controlling dopant at an amount that is sufficient to cover the majority of the ceramic matrix grain boundaries. One ceramic nanocomposite includes a ceramic matrix with submicron particles dispersed in the ceramic matrix, the submicron particles having a coefficient of thermal expansion lower than the coefficient of thermal expansion of the ceramic matrix and at least one dopant that covers the majority of the ceramic matrix grain boundaries, at a concentration that does not exceed the bulk solubility limit of the dopant in the ceramic matrix at the ceramic nanocomposite sintering temperature.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: January 5, 2016
    Assignee: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Wayne David Kaplan, Gali Gluzer, Moshe Katz, Gil Perlberg